Publications
5491 Results
- Journal / Conference
- ASCO Gastrointestinal Cancer Symposium (Jan 20-22, 2022, San Francisco, CA), TIPS poster session
- Year
- 2022
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S2104
Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide versus Observation in High-Risk Pancreatic Neuroendocrine Tumors: SWOG S2104
- Journal / Conference
- American Journal of Clinical Nutrition Jan 18;nqac013. doi: 10.1093/ajcn/nqac013. Online ahead of print.
- Year
- 2022
- Research Committee(s)
- Prevention and Epidemiology
- PMID
- PMID35040869
- Study Number(s)
- S0000C
Change in Plasma Alpha-Tocopherol Associations with Attenuated Pulmonary Function Decline and with CYP4F2 Missense Variation
- Journal / Conference
- Journal of Clinical Oncology May 10;40(14):1574-1582
- Year
- 2022
- Research Committee(s)
- Leukemia
- PMID
- PMID35157496
- PMC
- PMC9084435
- Study Number(s)
- S1318
SWOG 1318: A Phase 2 Trial of Blinatumomab Followed by POMP Maintenance in Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia
- Journal / Conference
- Journal of Clinical Oncology Mar 1;40(7):740-751; Jan 7;JCO2101784. doi: 10.1200/JCO.21.01784. Online ahead of print
- Year
- 2022
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID34995084
- PMC
- PMC8887946
- Study Number(s)
- C89803
Diet- and Lifestyle-Based Prediction Models to Estimate Cancer Recurrence and Death in Stage III Colon Cancer Patients (Alliance)
- Journal / Conference
- Journal of Clinical Oncology May 1;40(13):1474-1486
- Year
- 2022
- Research Committee(s)
- Cancer Care Delivery and Symptom Control and Quality of Life
- PMID
- PMID35119908
Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials
- Journal / Conference
- Journal of Clinical Oncology Jan 19;JCO2101506. doi: 10.1200/JCO.21.01506. Online ahead of print
- Year
- 2022
- Research Committee(s)
- Breast
- PMID
- PMID35044810
- Study Number(s)
- CTSU/C40603
CALGB/Alliance 40603: Long-term outcomes after neoadjuvant chemotherapy with or without carboplatin and bevacizumab in triple-negative breast cancer (TNBC)
- Journal / Conference
- PLOS Medicine Feb 3;19(2):e1003897
- Year
- 2022
- Research Committee(s)
- Prevention and Epidemiology
- PMID
- PMID35113855
- PMC
- PMC8812899
- Study Number(s)
- S0000
Genetically-proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers
- Journal / Conference
- BMC Medicine Jan 11;20(1):3
- Year
- 2022
- Research Committee(s)
- Cancer Control and Prevention and Epidemiology
- PMID
- PMID35012533
- PMC
- PMC8750876
- Study Number(s)
- S0000, SWOG-9217
Circulating Inflammatory Cytokines and Risk of Five Cancers: a Mendelian Randomization Analysis
- Journal / Conference
- PLOS Medicine Jan 27;19(1):e1003859. doi: 10.1371/journal.pmed.1003859. eCollection 2022 Jan
- Year
- 2022
- Research Committee(s)
- Cancer Control and Prevention and Epidemiology
- PMID
- PMID35085228
- PMC
- PMC8794090
- Study Number(s)
- S0000, SWOG-9217
The relationship between Lipoprotein A and Prostate Cancer risk: A multivariable Mendelian randomization study
- Journal / Conference
- Obesity Jan;30(1):28-38
- Year
- 2022
- Research Committee(s)
- Breast
- PMID
- PMID34932888
- Study Number(s)
- CTSU/A011401